Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation

FEBS Journal

Volumn 272, Issue 1, 2005, Pages 97-108

  Preston, Roger J S ^a   Villegas Mendez, Ana ^a   Sun, Yong Hui ^b   Hermida, José ^a,d   Simioni, Paolo ^c   Philippou, Helen ^a,e   Dahlbäck, Björn ^b   Lane, David A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^d UNIVERSITY OF NAVARRA   (Spain)

^e UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Activated protein C; Endothelial cell protein C receptor; Protein C

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5A; CELL RECEPTOR; ENDOTHELIAL CELL PROTEIN C RECEPTOR; PHOSPHOLIPID; PROTEIN C; RECOMBINANT PROTEIN; THROMBIN; THROMBOMODULIN; UNCLASSIFIED DRUG; VITAMIN K GROUP;

ARTICLE; BINDING AFFINITY; CELL SURFACE; DISSOCIATION CONSTANT; ENDOTHELIUM CELL; EQUILIBRIUM CONSTANT; HUMAN; HUMAN CELL; MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT; SURFACE PLASMON RESONANCE; WILD TYPE;

ANTIGENS, CD; BLOTTING, WESTERN; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOPROTEINS; HUMANS; MUTATION; PHOSPHOLIPIDS; PROTEIN BINDING; PROTEIN C; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; SURFACE PLASMON RESONANCE;

EID: 11444268040     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1432-1033.2004.04401.x     Document Type: Article

References (59)

1. Esmon CT (1992) The protein C anticoagulant pathway. Arterioscler Thromb 12, 135-145.
2. Simmonds RE & Lane DA (1998) Regulation of Coagulation. In Thrombosis and Hemorrhage (Loscalzo J & Schafer AI, eds). Williams and Watkins, Baltimore.
3. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL & Esmon CT (1996) The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA 93, 10212-10216.
4. Fukudome K, Ye X, Tsuneyoshi N, Tokunaga O, Sugawara K, Mizokami H & Kimoto M (1998) Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor. J Exp Med 187, 1029-1035.
5. Xu J, Esmon NL & Esmon CT (1999) Reconstitution of the human endothelial cell protein C receptor with thrombomodulin in phosphatidylcholine vesicles enhances protein C activation. J Biol Chem 274, 6704-6710.
6. Esmon CT, Ding W, Yasuhiro K, Gu JM, Ferrell G, Regan LM, Stearns-Kurosawa DJ, Kurosawa S, Mather T, Laszik Z & Esmon NL (1997) The protein C pathway: new insights. Thromb Haemost 78, 70-74.
7. Fay PJ, Smudzin TM & Walker FJ (1991) Activated protein C-catalyzed inactivation of human factor VIII and factor VIIIa. Identification of cleavage sites and correlation of proteolysis with cofactor activity. J Biol Chem 266, 20139-20145.
8. Kisiel W, Canfield WM, Ericsson LH & Davie EW (1977) Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 16, 5824-5831.
9. Walker FJ, Sexton PW & Esmon CT (1979) The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V. Biochim Biophys Acta 571, 333-342.
10. Kalafatis M, Rand MD & Mann KG (1994) The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269, 31869-31880.
11. Kalafatis M, Bertina RM, Rand MD & Mann KG (1995) Characterization of the molecular defect in factor VR506Q. J Biol Chem 270, 4053-4057.
12. Nicolaes GA, Tans G, Thomassen MC, Hemker HC, Pabinger I, Varadi K, Schwarz HP & Rosing J (1995) Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem 270, 21158-21166.
13. Kalafatis M & Mann KG (1993) Role of the membrane in the inactivation of factor Va by activated protein C. J Biol Chem 268, 27246-27257.
14. Norstrom E, Thorelli E & Dahlback B (2002) Functional characterization of recombinant FV Hong Kong and FV Cambridge. Blood 100, 524-530.
15. Riewald M, Petrovan RJ, Donner A, Mueller BM & Ruf W (2002) Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296, 1880-1882.
16. Cheng T, Liu D, Griffin JH, Fernandez JA, Castellino F, Rosen ED, Fukudome K & Zlokovic BV (2003) Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med 9, 338-342.
17. Bangalore N, Drohan WN & Orthner CL (1994) High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands. Thromb Haemost 72, 465-474.
18. Fukudome K & Esmon CT (1994) Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 269, 26486-26491.
19. Fukudome K, Kurosawa S, Stearns-Kurosawa DJ, He X, Rezaie AR & Esmon CT (1996) The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. J Biol Chem 271, 17491-17498.
20. Regan LM, Mollica JS, Rezaie AR & Esmon CT (1997) The interaction between the endothelial cell protein C receptor and protein C is dictated by the gamma-carboxyglutamic acid domain of protein C. J Biol Chem 272, 26279-26284.
21. Freedman SJ, Blostein MD, Baleja JD, Jacobs M, Furie BC & Furie B (1996) Identification of the phospholipid binding site in the vitamin K-dependent blood coagulation protein factor IX. J Biol Chem 271, 16227-16236.
22. Freedman SJ, Furie BC, Furie B & Baleja JD (1995) Structure of the calcium ion-bound gamma-carboxyglutamic acid-rich domain of factor IX. Biochemistry 34, 12126-12137.
23. Soriano-Garcia M, Park CH, Tulinsky A, Ravichandran KG & Skrzypczak-Jankun E (1989) Structure of Ca2+ prothrombin fragment 1 including the conformation of the Gla domain. Biochemistry 28, 6805-6810.
24. Soriano-Garcia M, Padmanabhan K, de Vos AM & Tulinsky A (1992) The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry 31, 2554-2566.
25. Oganesyan V, Oganesyan N, Terzyan S, Qu D, Dauter Z, Esmon NL & Esmon CT (2002) The crystal structure of the endothelial protein C receptor and a bound phospholipid. J Biol Chem 277, 24851-24854.
26. Falls LA, Furie BC, Jacobs M, Furie B & Rigby AC (2001) The omega-loop region of the human pro thrombin gamma-carboxyglutamic acid domain penetrates anionic phospholipid membranes. J Biol Chem 276, 23895-23902.
27. Huang M, Rigby AC, Morelli X, Grant MA, Huang G, Furie B, Seaton B & Furie BC (2003) Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nat Struct Biol 10, 751-756.
28. Simmonds RE & Lane DA (1999) Structural and functional implications of the intron/exon organization of the human endothelial cell protein C/activated protein C receptor (EPCR) gene: comparison with the structure of CD1/major histocompatibility complex alpha1 and alpha2 domains. Blood 94, 632-641.
29. Villoutreix BO, Blom AM & Dahlback B (1999) Structural prediction and analysis of endothelial cell protein C/activated protein C receptor. Protein Eng 12, 833-840.
30. Fukudome K & Esmon CT (1995) Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR). The structural and functional conservation in human, bovine, and murine EPCR. J Biol Chem 270, 5571-5577.
31. Liaw PC, Mather T, Oganesyan N, Ferrell GL & Esmon CT (2001) Identification of the protein C/activated protein C binding sites on the endothelial cell protein C receptor. Implications for a novel mode of ligand recognition by a major histocompatibility complex class 1-type receptor. J Biol Chem 276, 8364-8370.
32. Reitsma PH, Bernardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Lind B, Long GL, Poort SR et al. (1995) Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 73, 876-889.
33. Christiansen WT, Jalbert LR, Robertson RM, Jhingan A, Prorok M & Castellino FJ (1995) Hydrophobie amino acid residues of human anticoagulation protein C that contribute to its functional binding to phospholipid vesicles. Biochemistry 34, 10376-10382.
34. Christiansen WT, Tulinsky A & Castellino FJ (1994) Functions of individual gamma-carboxyglutamic acid (Gla) residues of human protein C. Determination of functionally nonessential Gla residues and correlations with their mode of binding to calcium. Biochemistry 33, 14993-15000.
35. Jalbert LR, Chan JC, Christiansen WT & Castellino FJ (1996) The hydrophobic nature of residue-5 of human protein C is a major determinant of its functional interactions with acidic phospholipid vesicles. Biochemistry 35, 7093-7099.
36. Shen L, Shah AM, Dahlback B & Nelsestuen GL (1997) Enhancing the activity of protein C by mutagenesis to improve the membrane-binding site: studies related to proline-10. Biochemistry 36, 16025-16031.
37. Sun YH, Shen L & Dahlback B (2003) Gla domain-mutated human protein C exhibiting enhanced anticoagulant activity and increased phospholipid binding. Blood 101, 2277-2284.
38. Zhang L & Castellino FJ (1993) The contributions of individual gamma-carboxyglutamic acid residues in the calcium-dependent binding of recombinant human protein C to acidic phospholipid vesicles. J Biol Chem 268, 12040-12045.
39. Nelsestuen GL (1999) Enhancement of vitamin-K-dependent protein function by modification of the gamma-carboxyglutamic acid domain: studies of protein C and factor VII. Trends Cardiovasc Med 9, 162-167.
40. Regan LM, Stearns-Kurosawa DJ, Kurosawa S, Mollica J, Fukudome K & Esmon CT (1996) The endothelial cell protein C receptor. Inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitors. J Biol Chem 271, 17499-17503.
41. Shen L, Villoutreix BO & Dahlback B (1999) Involvement of Lys 62 (217) and Lys 63 (218) of human anticoagulant protein C in heparin stimulation of inhibition by the protein C inhibitor. Thromb Haemost 82, 72-79.
42. Shen L, Villoutreix BO & Dahlback B (1999) Interspecies loop grafting in the protease domain of human protein C yielding enhanced catalytic and anticoagulant activity. Thromb Haemost 82, 1078-1087.
43. Sala N, Owen WG & Collen D (1984) A functional assay of protein C in human plasma. Blood 63, 671-675.
44. Norstrom EA, Steen M, Tran S & Dahlback B (2003) Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va. J Biol Chem 278, 24904-24911.
45. Wojcik EG, Simioni P, de Berg M, Girolami A & Bertina RM (1996) Mutations which introduce free cysteine residues in the Gla-domain of vitamin K dependent proteins result in the formation of complexes with alpha 1-microglobulin. Thromb Haemost 75, 70-75.
46. Ido M, Ohiwa M, Hayashi T, Nishioka J, Hatada T, Watanabe Y, Wada H, Shirakawa S & Suzuki K (1993) A compound heterozygous protein C deficiency with a single nucleotide G deletion encoding Gly-381 and an amino acid substitution of Lys for Gla-26. Thromb Haemost 70, 636-641.
47. Nishioka J, Ido M, Hayashi T & Suzuki K (1996) The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va. Thromb Haemost 75, 275-282.
48. Stearns-Kurosawa DJ, Mather T, Kurosawa S & Esmon CT (1999) The binding site on protein C for the endothelial cell protein C receptor. Blood 94, 2878.
49. McDonald JF, Shah AM, Schwalbe RA, Kisiel W, Dahlback B & Nelsestuen GL (1997) Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site. Biochemistry 36, 5120-5127.
50. Faioni EM, Hermida J, Rovida E, Razzari C, Asti D, Zeinali S & Mannucci PM (2000) Type II protein C deficiency: identification and molecular modelling of two natural mutants with low anticoagulant and normal amidolytic activity. Br J Haematol 108, 265-271.
51. Marshall JC (2003) Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov 2, 391-405.
52. Domotor E, Benzakour O, Griffin JH, Yule D, Fukudome K & Zlokovic BV (2003) Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1. Blood 101, 4797-4801.
53. Hermida J, Hurtado V, Villegas-Mendez A, Catto AJ & Philippou H (2003) Identification and characterization of a natural R96C EPCR variant. J Thromb Haemost 1, 1850-1852.
54. Simioni P, Kalafatis M, Tormene D, Luni S, Zerbinati P, Barzon L, Palu G & Girolami A (2001) Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma: characterization of the dysfunctional protein C Padua3 (protein C (R-1L/propeptide). Thromb Haemost 86, 1017-1022.
55. Rezende SM, Lane DA, Zoller B, Mille-Baker B, Laffan M, Dahlback B & Simmonds RE (2002) Genetic and phenotypic variability between families with hereditary protein S deficiency. Thromb Haemost 87, 258-265.
56. Zhang L & Castellino FJ (1990) A gamma-carboxyglutamic acid (gamma) variant (gamma 6D, gamma 7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Biochemistry 29, 10828-10834.
57. Yang L, Manithody C & Rezaie AR (2002) Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C. Biochemistry 41, 6149-6157.
58. Edgell CJ, McDonald CC & Graham JB (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80, 3734-3737.
59. Suzuki K, Kusumoto H, Deyashiki Y, Nishioka J, Maruyama I, Zushi M, Kawahara S, Honda G, Yamamoto S & Horiguchi S (1987) Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 6, 1891-1897.